NCT01685190 - A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer | Biotech Hunter

Enrollment

124

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2019

Conditions

Prostate Cancer

Interventions

RADIATION

Prostate alone IMRT

Participants will receive standard prostate IMRT of 74Gy in 37 fractions delivered over 7.5 weeks.

RADIATION

Prostate and pelvis IMRT

Participants will receive prostate and pelvis IMRT with a dose of 74Gy in 37 fractions delivered over 7.5 weeks to the prostate and 60Gy in 37 fractions delivered over 7.5weeks to the pelvis.

Trial Locations (7)

Unknown

Queen Elizabeth, Birmingham

Addenbrooke's Hospital, Cambridge

Velindre Hospital, Cardiff

Ipswich, Ipswich

Clatterbridge Centre for Oncology, Liverpool

Royal Marsden NHSFT, London

Freeman Hospital, Newcastle